Model DetailsBlood vessel hemangioma
Model Name |
Blood vessel hemangioma | Strain |
(C57BL/6 x C3H)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
hemangioma • circulatory system hemangioma |
Strain Synonyms |
B6C3F1 • (C57BL/6xC3H) • F1-hybrid B6C3F1 • B6C3F1 • hybrid B6C3F1 • B6C3F1 (C3H x C57B16) • B6C3F1 hybrid |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Blood vessel | Male |
0% (0 of 65 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 80 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
3.3% (2 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
4.3% (3 of 70 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
1.5% (1 of 65 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
0% (0 of 70 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
1.5% (1 of 65 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 80 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
4.0% (2 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
1.7% (1 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
4.3% (3 of 70 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
6.0% (3 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
0% (0 of 65 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
4.0% (2 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% (1 of 50 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
2.0% |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
3.3% (2 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
6.7% (4 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
5.0% (3 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
1.7% (1 of 60 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Female |
3.2% (4 of 125 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
5% (6 of 120 mice) |
|
Duddy SK, Toxicol Appl Pharmacol 1999 Apr 15;156(2):106-12 | |
| Blood vessel | Male |
1.0% (2 of 200 mice) |
|
Chandra M, Toxicol Lett 1992 Jan;60(1):91-8 | |
| Blood vessel | Female |
1.5% (3 of 200 mice) |
|
Chandra M, Toxicol Lett 1992 Jan;60(1):91-8 | |
| Blood vessel | Male |
0.5% (7 of 1355 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
4% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
1.0% (11 of 1100 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
4% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
1.6% (22 of 1353 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
1.7% (19 of 1092 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
0% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Female |
6% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Blood vessel | Male |
1.5% (34 of 2343 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Blood vessel | Female |
1.6% (39 of 2486 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |